XERS
|Xeris Pharmaceuticals Inc
NASDAQ
USD 4.65
-0.40|-7.92%
Current Price
USD 4.65
Change
USD -0.40 (-7.92%)
P/E Ratio
Dividend Yield
Market Cap
813.59M
Volume
5.10M
Open
USD 5.03
Previous Close
USD 5.05
52-Week High
USD 6.07
52-Week Low
USD 1.86
About Xeris Pharmaceuticals Inc
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the...
Sector:Healthcare
Industry:Biotechnology
CEO:Mr. John P. Shannon
Employees:394
Headquarters:Chicago, USA
Website:www.xerispharma.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions